AlphAIAlphAI — Financial news for AI agents
SEC EDGAROCT 221 min read$MNDY

Eyal Aviad sold $200K of MNDY

Eyal Aviad sold 2,000 shares of monday.com Ltd. (MNDY) at $100.04 ($0.20M total) on 2026-10-20 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Eyal Aviad
Published Oct 22, 2026, 8:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 8:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$MNDY
Bearish
medium confidence
Mentioned
$MNDY
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MNDYBearishLow
01

Why it matters

The disclosed sale adds a data point for investors monitoring insider activity.

02

Market read

Small insider sale with limited immediate market impact but useful for monitoring insider trends.

03

What to watch

Potential upcoming product announcements or earnings could offset the sell pressure.

Relevance 3/10Novelty 3/10Timing: post‑market filing on Oct 22

Background

SEC Form 4 filing discloses insider transactions required for transparency.

Company-level read

Ticker impact

$MNDYBearishMedium confidence
Context

Director Eyal Aviad sold 2,000 shares of monday.com for $200,079 via a pre‑arranged 10b5‑1 plan.

Expected impact

likely modest downward pressure as the market prices the director's sell order

Evidence & confidence

A $200k sale by a director is small relative to market cap, but signals potential short‑term supply.

Market effects

Sector

Minimal impact on the broader SaaS sector.

Regional

No significant regional effect.

Global

Limited to monday.com investors.

Counterpoint

What could challenge this read

The sale may be routine under a 10b5‑1 plan and not indicative of insider concern.

Key entities

  • Director
    Eyal Aviad

    Director of monday.com who executed the sale.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

MNDY insider trading history →

Related articles

OCT 17
$MNDYMed

Monday faces senior management exits amid AI restructuring

Israeli software company monday.com (MNDY) expects several senior management departures amid a restructuring and shift to AI-powered work platforms. The company announced a 20% workforce reduction in July, with restructuring costs estimated at $45M-$55M. Q2 2026 revenue was $364.6M, up 22% YoY, with net profit at $3.46M. Shares closed at $90, down 4% on the day and 37% YTD.

calcalistech.com2 min
OCT 17
$CRMMed

Notable analyst calls: Salesforce, Walmart and Lockheed Martin gain analyst support as tech downgrades mount

Bank of America upgraded Salesforce (CRM) to Buy, raising its price target to $285, citing AI adoption and strong free cash flow. Barclays downgraded Dell (DELL), HPE (HPE), NetApp (NTAP), HubSpot (HUBS), and monday.com (MNDY) due to AI growth concerns. Deutsche Bank upgraded Walmart (WMT) to Buy, targeting $136, citing inflation benefits. RBC downgraded GoDaddy (GDDY) to Sector Perform, citing AI's impact. MongoDB (MDB) ratings reaffirmed by Needham and BofA.

tradingview.com3 min
OCT 12
$MNDYMed

Barclays downgrades 2 software stocks ahead of Q3 earnings

Barclays downgraded HubSpot and Monday.com to Equal Weight, citing delayed AI-driven growth. Analyst Raimo Lenschow expects AI growth at DigitalOcean and Datadog, and emerging at Microsoft. DigitalOcean and CoreWeave raised prices due to AI demand, with potential for revenue beats. Payroll software companies Paycom and Paylocity may see earnings beats.

finance.yahoo.com2 min
SEP 30
$MNDYMed

Why is Monday.com stock rallying today?

Monday.com (MNDY) stock rose 5% after a prior downgrade and decline. JPMorgan cut its rating to Neutral, citing growth concerns. The company announced an AI-focused conference, and softer inflation data boosted tech stocks. Shares traded at $79.81, below the 52-week high of $210.49 but above the low of $57.50.

investing.com2 min